Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Exp Hematol. 2010 Oct;38(10):933-44. doi: 10.1016/j.exphem.2010.06.005. Epub 2010 Jun 22.
Cumulative evidence supports that Epstein-Barr virus (EBV)-infected natural killer (NK) cells induce severe systemic and cutaneous inflammation in patients with hypersensitivity to mosquito bites (HMB). In order to understand the pathogenesis of HMB, we established an EBV-infected cell line and characterized the cytological profiles.
A novel EBV-infected NK-cell line, designated NKED, was established from a patient with HMB and used for the present study along with two other NK-cell lines, KAI3 and KHYG-1.
NKED expressed the latency II-related transcripts. NKED cells were positive for CD2 and CD161 antigens, and negative for CD3, CD16, CD34, CD56, and T-cell receptor α/β and γ/δ antigens. Although NKED cells contained several cytotoxic molecules, the cells had an extremely poor cytotoxic activity. The majority of NKED cells were negative for perforin, major histocompatibility complex class I-restricted NK-cell receptors, CD94 and KIR2D, and an activating receptor, NKG2D. NKED cells, however, secreted higher levels of tumor necrosis factor-α. Stimulation with phorbol 12-myristate 13-acetate or tumor necrosis factor-α induced expression of BZLF1 messenger RNA in the NKED and KAI3 cells, indicating the transition from the latent- to the lytic-cycle infection.
These data suggested that NKED cells revealed a very low cytotoxic effect probably because of the low expression levels of perforin, but had the ability to release proinflammatory cytokines. NKED cells did not reflect the characteristics of HMB, as they were different from pathogenic NK cells proliferating in the HMB patient, but the difference indicated that pathogenic NK cells could change their character in the presence of interleukin-2.
越来越多的证据表明,感染爱泼斯坦-巴尔病毒(EBV)的自然杀伤(NK)细胞会在蚊虫叮咬过敏(HMB)患者中引发严重的全身和皮肤炎症。为了了解 HMB 的发病机制,我们建立了 EBV 感染的细胞系,并对其细胞学特征进行了描述。
我们从一名 HMB 患者中建立了一种新型 EBV 感染的 NK 细胞系,命名为 NKED,并与另外两种 NK 细胞系 KAI3 和 KHYG-1 一起用于本研究。
NKED 表达潜伏 II 相关转录物。NKED 细胞表达 CD2 和 CD161 抗原,而不表达 CD3、CD16、CD34、CD56、T 细胞受体 α/β 和 γ/δ 抗原。尽管 NKED 细胞含有几种细胞毒性分子,但细胞的细胞毒性活性极差。大多数 NKED 细胞不表达穿孔素、主要组织相容性复合物 I 限制的 NK 细胞受体 CD94 和 KIR2D,以及激活受体 NKG2D。然而,NKED 细胞分泌更高水平的肿瘤坏死因子-α。佛波醇 12-肉豆蔻酸 13-乙酸酯或肿瘤坏死因子-α刺激诱导 NKED 和 KAI3 细胞中 BZLF1 信使 RNA 的表达,表明从潜伏期到裂解期感染的转变。
这些数据表明,NKED 细胞显示出极低的细胞毒性效应,可能是由于穿孔素表达水平较低,但具有释放促炎细胞因子的能力。NKED 细胞并不反映 HMB 的特征,因为它们与在 HMB 患者中增殖的致病性 NK 细胞不同,但这种差异表明致病性 NK 细胞在存在白细胞介素-2 的情况下可以改变其特性。